October 2024 FDA Recall Drug by Padagis Us Llc
D-0048-2025 - Subpotent and Superpotent Drug. Out of specification assay results recorded as part of Uniformity of Container test during long-term stability testing.

This Class III drug recall was voluntarily initiated by Padagis Us Llc on October 11, 2024 for the product Drug. The FDA reported the reason for recall as subpotent and superpotent drug. out of specification assay results recorded as part of uniformity of container test during long-term stability testing.. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0048-2025

Reason for Recall
Subpotent and Superpotent Drug. Out of specification assay results recorded as part of Uniformity of Container test during long-term stability testing.
Initiated
10-11-2024
Reported
11-27-2024
Quantity
10,872 jars

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Nationwide in the USA
Triamcinolone Acetonide Cream USP, 0.025%, 1 LB (454 g) per jar, Rx Only, Manufactured By Padagis, Minneapolis, MN 55427. NDC: 45802-0063-05

Batch or Lot Expiration Information

Lot# : 2024154238, 2024174344, Exp. Date 3/31/2026